Beat Flühmann
Impact in
- Hematology top 5%
- Iron Metabolism and Disorders
- Erythropoietin and Anemia Treatment
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Hematology 12
- Iron Metabolism and Disorders 12
- Erythropoietin and Anemia Treatment 4
-
- Pharmaceutical Economics and Policy 9
- Health Systems, Economic Evaluations, Quality of Life 3
- Co-authors
- Stefan Mühlebach (13 shared papers)Gerrit Borchard (9 shared papers)Vinod P. Shah (9 shared papers)Daan J.A. Crommelin (6 shared papers)Vera Weinstein (5 shared papers)Jon S. B. de Vlieger (5 shared papers)Ioanna Ntai (2 shared papers)Scott E. McNeil (4 shared papers)
- Journals
- Generics and Biosimilars Initiative Journal (5 papers)European Journal of Pharmaceutical Sciences (3 papers)Annals of the New York Academy of Sciences (3 papers)Journal of Controlled Release (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- SwitzerlandUnited StatesNetherlands
In The Last Decade
Beat Flühmann
29 papers receiving 590 citations
Peers
Comparison fields: 5 of 93
- Hematology 138
- Biomaterials 151
- Pharmaceutical Science 44
- Genetics 56
- Immunology 107
Countries citing papers authored by Beat Flühmann
This map shows the geographic impact of Beat Flühmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beat Flühmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beat Flühmann more than expected).
Fields of papers citing papers by Beat Flühmann
This network shows the impact of papers produced by Beat Flühmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beat Flühmann. The network helps show where Beat Flühmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Beat Flühmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 74 | |
| 2 | 2018 | 68 | |
| 3 | 2017 | 61 | |
| 4 | 2015 | 55 | |
| 5 | 2012 | 46 | |
| 6 | 2020 | 40 | |
| 7 | 2019 | 30 | |
| 8 | 2017 | 26 | |
| 9 | 2022 | 25 | |
| 10 | 2021 | 21 | |
| 11 | 2018 | 19 | |
| 12 | 2021 | 18 | |
| 13 | 2021 | 18 | |
| 14 | Bonistein (synthetic genistein), a food component in development for a bone health nutraceutical. | 2005 | 17 |
| 15 | 2013 | 16 | |
| 16 | 2022 | 11 | |
| 17 | 2017 | 11 | |
| 18 | 2024 | 10 | |
| 19 | 2022 | 8 | |
| 20 | 2015 | 8 |
About Beat Flühmann
Beat Flühmann is a scholar working on Hematology, Economics and Econometrics, Genetics, Immunology and Biomaterials, having authored 32 papers that have together received 617 indexed citations. Recurring topics across this work include Iron Metabolism and Disorders (12 papers), Pharmaceutical Economics and Policy (9 papers), Hemoglobinopathies and Related Disorders (7 papers), Biosimilars and Bioanalytical Methods (7 papers), Nanoparticle-Based Drug Delivery (6 papers), Pharmaceutical studies and practices (5 papers), Erythropoietin and Anemia Treatment (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). The work is most often cited by research in Hematology (138 citations), Biomaterials (151 citations), Pharmaceutical Science (44 citations), Genetics (56 citations) and Immunology (107 citations). Beat Flühmann has collaborated with scholars based in Switzerland, United States and Netherlands. Frequent co-authors include Stefan Mühlebach, Gerrit Borchard, Vinod P. Shah, Daan J.A. Crommelin, Vera Weinstein, Jon S. B. de Vlieger, Ioanna Ntai, Scott E. McNeil, Steven Simoens and Felix Funk. Their work appears in journals such as Generics and Biosimilars Initiative Journal, European Journal of Pharmaceutical Sciences, Annals of the New York Academy of Sciences, Journal of Controlled Release and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.